» Articles » PMID: 12461278

Breast MR Imaging in Women at Increased Lifetime Risk of Breast Cancer: Clinical System for Computerized Assessment of Breast Lesions Initial Results

Overview
Journal Radiology
Specialty Radiology
Date 2002 Dec 4
PMID 12461278
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The authors developed a clinical system for computerized delineation, rating, and classification of breast lesions depicted in contrast material-enhanced magnetic resonance images obtained in women with increased lifetime risk of breast cancer. Initial results showed negative predictive values above 98% at 50% positive predictive value with negligible interoperator differences. The system demonstrated potential to help exclude malignancy with high confidence and reproducibility with a positive predictive value that is acceptable in screening.

Citing Articles

Type 2 dynamic curves: A diagnostic dilemma.

Karavas E, Ece B, Aydin S World J Radiol. 2022; 14(7):229-237.

PMID: 36160627 PMC: 9350610. DOI: 10.4329/wjr.v14.i7.229.


Synchronous Breast Cancer: Phenotypic Similarities on MRI.

Wang H, H M van der Velden B, Chan H, Loo C, Viergever M, Gilhuijs K J Magn Reson Imaging. 2019; 51(6):1858-1867.

PMID: 31854487 PMC: 7318126. DOI: 10.1002/jmri.27026.


Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients.

H M van der Velden B, Sutton E, Carbonaro L, Pijnappel R, Morris E, Gilhuijs K Eur Radiol. 2018; 28(11):4705-4716.

PMID: 29736850 PMC: 6182741. DOI: 10.1007/s00330-018-5470-7.


Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.

Schmitz A, Teixeira S, Pengel K, Loo C, Vogel W, Wesseling J PLoS One. 2017; 12(5):e0176782.

PMID: 28531188 PMC: 5439668. DOI: 10.1371/journal.pone.0176782.


Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer.

Loo C, Rigter L, Pengel K, Wesseling J, Rodenhuis S, Vrancken Peeters M Breast Cancer Res. 2016; 18(1):82.

PMID: 27495815 PMC: 4975876. DOI: 10.1186/s13058-016-0742-0.